The reverse stock split is intended to increase the market price per share of ADMP's common stock to regain compliance with Nasdaq's minimum bid price requirement. This is important for maintaining its listing on Nasdaq and for the completion of its merger with DMK Pharmaceuticals. However, the short-term impact on the stock price is uncertain, as the market may react positively to the company's efforts to regain compliance and complete the merger, or negatively due to the dilution effect of the reverse split.